Misophonia: an imaging study on the neurobiology and the efficacy of cognitive behavioural therapy

Misophonia: an imaging study on the neurobiology and the efficacy of cognitive behavioural therapy - Misophonia: an imaging study on the neurobiology

Status

Active, not recruiting

Phases

Phase 2

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35548

Enrollment

Registered

2012-01-16

Start date

2012-03-12

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hatred of sound

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Symptoms of misophonia 18-65 yrs

Exclusion criteria

Exclusion criteria: Major Depression Anxiety disorders Bipolar disorder Autism Spectrum Disorders Psychotic disorders Epilepsia/CNS disorders

Design outcomes

Primary

Measure	Time frame
Main study parameters: - Change in symptom severity as measured with the Amsterdam Misophonia Scale (AMISS) and Clinical Global Impression Scale (CGI) - fMRI - EEG - Neuropsychological paradigms - Genetic outcomes	—

Secondary

Measure	Time frame
Psychiatric questionnaires (HARS, HDRS, IOA, AVL, SCL-90R)	—

Countries

Netherlands

Outcome results